INTRODUCTION

6
Factor B (Figure 4A by treatment with IL-1-Ra. Splenic noradrenaline levels are increased after experimental stroke and may be toxic to IgM . Maximum noradrenaline concentration measured in the first 7 days after 2 1 4 stroke was increased in both placebo and IL-1Ra treated patients in comparison to non-stroke in the first 7 days after stroke was also measured and was not significantly different to non- The IL-1 family of cytokines play a critical role in host defence to pathogens by signalling to 2 2 2 a variety of host cells to induce downstream effects including, but not limited to, pro-2 2 3 inflammatory cytokine and chemokine production, immune cell recruitment and upregulation 2 2 4 of vascular adhesion molecules 10, 11 . However, in conditions of sterile inflammation and tissue injury, such as stroke, these effects can aggravate primary tissue damage and impair injury repair mechanisms. Blocking IL-1 signalling has shown improved outcome in both 2 2 7 experimental animal and patient stroke studies 1, 4, 12 . However, the immunosuppressive infection, further increasing the risk of infection in patients who are already immune concentrations and is therefore unlikely to further compromise immune defence against
infection through reducing the availability of these antibacterial mediators. production. IL-1β was reported to be important for the rapid production of anti-bacterial IgM stroke that are associated with stroke risk. However, control patients in this study were show similar changes to stroke patients if these were associated with risk factors.
Understanding the kinetics of individual immunoglobulin subset changes both preceding, and The complement system has a crucial role in enhancing humoral immune defence and
protecting from bacterial infection via interactions with both the innate and adaptive immune 2 8 7 systems 22 .
As activation of complement is closely associated with efficient
immunoglobulin-mediated clearance of pathogens, we determined if these pathways were compromised by stroke. We have assessed for the first time, individual concentrations of
multiple complement components covering all pathways of complement activation after
stroke. These exploratory data suggest there are no overall deficits in complement activation when IgM or IgG immune complexes bind to C1 (composed of C1q, C1r and C1s) 22, 23 .
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Maximum circulating concentration of complement components associated with the classical
and lectin pathways of activation, C1q, C2 and C4b and end stage mediators common to all
pathways, C5 and C9 were increased in the first 7 d after stroke in comparison to non-stroke 2 9 8
controls. As concentrations of MBL itself was not significantly altered by stroke, this
suggests the classical complement pathway is specifically activated after stroke. In contrast, the alternative pathway of complement activation is initiated by microbial cell Complement components that were significantly downregulated after stroke, C3b/ iC3b, C3,
Factor H (fH) and Properdin, are more associated with the alternative pathway of stroke whereas C3c, associated with the alternative pathway, was reduced 24, 25 . The roles of
individual pathways of complement activation in infection susceptibility after stroke remains
to be determined but these data suggest overall deficits in complement concentration are influence on infection susceptibility. In this study, circulating noradrenaline concentrations measured in the first week after stroke
were increased in comparison to non-stroke controls but were not influenced by treatment sympathetic nervous system in both stroke and subarachnoid haemorrhage patients that 3 2 0 resulted in increased plasma noradrenaline concentrations that persisted up to 10 days [26] [27] [28] .
Our previous studies have shown that after experimental stroke, activation of the sympathetic 3 2 2 nervous system and release of noradrenaline within the spleen is toxic to resident B cells and
preventing noradrenaline signalling using the β-blocker propranolol prevented B cell and
IgM loss and resulted in reduced infectious burden 6 . The cytokine IL-1β is also increased in
the spleen after stroke and is reported to activate peripheral nerves, including the splenic
nerve, and increase production of splenic noradrenaline 29, 30 . However blockade of IL-1β
signalling did not alter circulating concentrations of noradrenaline after stroke. In summary, we have shown that treatment with IL-1Ra after stroke does not affect and is therefore unlikely to further increase patient susceptibility to infection via pathways in 3 3 2 which these mediators are key participants. This is in agreement with data from IL-1Ra
Phase 2 trials in which treatment of stroke patients with IL-1Ra did not aggravate incidence
of infection 4, 31 . These data suggest that blocking IL-1 in a stroke context may not be
concerning from the perspective of increasing infection risk in patients. Additionally, the reductions in circulating immunoglobulin concentrations detected after stroke in this study
further support that antibody mediated immune defence may be an important therapeutic
target to reduce the burden of infection after stroke. We thank Dr Hedley Emsley for recruitment of patients and data collection during the original stroke patient study, and for all the participating patients and controls for their panel kits used in this study. 
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